Principal Financial Group
RLAY icon

Principal Financial Group’s Relay Therapeutics RLAY Stock Holding History

Principal Financial Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,580
Closed -$95.1K – 2379
2024
Q2 		$95.1K Sell
14,580
-11,195
-43% -$76.5K ﹤0.01% 2224
2024
Q1 		$214K Sell
25,775
-1,880
-7% -$18.3K ﹤0.01% 2162
2023
Q4 		$304K Sell
27,655
-2,809
-9% -$23.7K ﹤0.01% 2060
2023
Q3 		$256K Buy
30,464
+4,507
+17% +$48.5K ﹤0.01% 2099
2023
Q2 		$326K Sell
25,957
-751
-3% -$9.34K ﹤0.01% 2051
2023
Q1 		$440K Buy
26,708
+3,020
+13% +$54.2K ﹤0.01% 1996
2022
Q4 		$354K Buy
23,688
+3,040
+15% +$58.2K ﹤0.01% 2062
2022
Q3 		$462K Buy
20,648
+3,899
+23% +$85.6K ﹤0.01% 1979
2022
Q2 		$280K Sell
16,749
-5,723
-25% -$123K ﹤0.01% 2203
2022
Q1 		$673K Buy
22,472
+72
+0.3% +$1.75K ﹤0.01% 2057
2021
Q4 		$688K Sell
22,400
-7,776
-26% -$246K ﹤0.01% 2055
2021
Q3 		$952K Buy
30,176
+326
+1% +$11K ﹤0.01% 2016
2021
Q2 		$1.09M Buy
29,850
+21,147
+243% +$697K ﹤0.01% 2019
2021
Q1 		$301K Buy
8,703
+1,852
+27% +$80.4K ﹤0.01% 2275
2020
Q4 		$285K Buy
+6,851
New +$310K ﹤0.01% 2247

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Principal Financial Group's RLAY Position: Q3 2024 in Review

Principal Financial Group sold out of Relay Therapeutics (RLAY) in Q3 2024, closing a stake of 14,580 shares — an estimated $95.1K sold.

Principal Financial Group first reported a position in RLAY in Q4 2020 and held it in 15 quarters. The position peaked at $1.09M in Q2 2021. 195 funds tracked by Wall St. Rank hold RLAY as of Q3 2024.

  • Principal Financial Group reported no remaining Relay Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 14,580 Relay Therapeutics shares in Q3 2024, an estimated $95.1K.
  • Principal Financial Group first reported a position in Relay Therapeutics in Q4 2020 and held it in 15 quarters.
  • Principal Financial Group's Relay Therapeutics position peaked at $1.09M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.